Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVRX | Common Stock | Conversion of derivative security | +3.5M | 3.5M | Jul 2, 2021 | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVRX | Series D-2 Preferred Stock | Conversion of derivative security | $0 | -4.03M | -100% | $0.00* | 0 | Jul 2, 2021 | Common Stock | 102K | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 | |
transaction | CVRX | Series E-2 Preferred Stock | Conversion of derivative security | $0 | -6.45M | -100% | $0.00* | 0 | Jul 2, 2021 | Common Stock | 163K | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 | |
transaction | CVRX | Series F-2 Preferred Stock | Conversion of derivative security | $0 | -7.59M | -100% | $0.00* | 0 | Jul 2, 2021 | Common Stock | 192K | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 | |
transaction | CVRX | Series G Preferred Stock | Conversion of derivative security | $0 | -48.1M | -100% | $0.00* | 0 | Jul 2, 2021 | Common Stock | 3.04M | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 |
Id | Content |
---|---|
F1 | Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock. |
F2 | These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person. |